评估皮质类固醇在后传染性淋巴结膜炎中的潜在作用
Theerachai Thammathiwat1, Talerngsak Kanjanabuch2,3,4, Athiphat Banjongjit5
1Division of Nephrology, Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
Glomerular diseases
|December 22, 2025
概括
皮质类固醇可以改善后传染性血球腺炎 (PIGN) 的存活率,但高累积剂量 (≥73 mg/kg) 会增加死亡风险. 较低剂量可能有利于严重的PIGN患者,这需要进一步研究最佳的皮质类固醇策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 后传染性淋巴结膜炎 (PIGN) 管理通常涉及皮质类固醇,但最佳剂量和长期结果尚未明确.
- 了解累积皮质类固醇剂量对PIGN死亡率的影响对于临床实践至关重要.
研究的目的:
- 调查皮质类固醇累积剂量与活检证明PIGN的患者的死亡率之间的关联.
- 为了确定最佳的累积普雷迪尼索隆剂量,以改善PIGN的存活率.
主要方法:
- 活检证明PIGN的成年患者的回顾性队列研究 (1996-2023年).
- 分析包括时间到事件,后勤回归,考克斯模型,ROC曲线和Kaplan-Meier生存分析.
- 主要结局是功能衰竭;次要结局包括死亡率和不良事件.
主要成果:
- 类固醇使用与较高的皮肤/软组织感染发病率有关,但与较低的死亡率独立相关 (HR 0.08).
- 在接受累积普得尼索隆≥73毫克/千克或不服用类固醇的患者中观察到明显较低的整体存活率.
- 累积普雷迪尼索隆<73毫克/公斤时观察到最佳生存期;常见的不良事件包括形外观和骨质疏松症.
结论:
- 皮质类固醇似乎可以改善PIGN的存活率,但累计剂量为73mg/kg或更高的剂量与死亡风险增加有关.
- 低剂量皮质类固醇可能在严重的PIGN中提供益处,需要进一步研究以优化剂量策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405
Nephrotic Syndrome I : Introduction
460
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
460
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Acute Kidney Injury II: Pathophysiology
840
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
840
Acute Kidney Injury III: Clinical Manifestations
763
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
763
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179


